EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis

Xiang Li, Gao He, Hui Jin, Xinyu Xiang, Dong Li, Renmiao Peng, Jing Tao, Xinping Li, Kaiyang Wang, Yu Luo iD, Xiaoan Liu

Advanced Science · 2025-02 · 12 (5)

DOI: 10.1002/advs.202407609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.12.2024. Verfasst von Xiang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid-Breast Surgery, The Fourth Affiliated Hospital of Nanjing Medical University, 298 Nanpu Road, Nanjing, Jiangsu, 210032, P. R. C…. Hauptthemen laut MEDLINE: Immunotherapy, Breast Neoplasms, Pulmonary Fibrosis, Ultrasonic Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Shuguang Plan, Jiangsu Province Capability Improvement Project through Science, Technology and Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors have demonstrated remarkable efficacy across various cancer types. However, immune‐related adverse events (irAEs) pose a significant challenge in immunotherapy, particularly the associated pneumonia as the primary adverse reaction, which can lead to irreversible pulmonary fibrosis. Additionally, monotherapy with programmed death ligand (PD‐L1) inhibitors has shown limited effectiveness. Therefore, to improve the response rate of immunotherapy and reduce pulmonary fibrosis, this study designed and prepared an intelligent nanodrug based on dendritic mesoporous silica nanoparticles (DMSNs) loaded with a sono‐sensitive agent protoporphyrin IX (PpIX). Additionally, a reactive oxygen species (ROS) sensitive linker is used to attach the immunotherapeutic drug PD‐L1 inhibitor (aPD‐L1) to DMSNs via covalent bonds. The external ultrasound (US) activates PpIX to generate ROS, which breaks the linker to release aPD‐L1 to induce sonodynamic therapy (SDT) and immunotherapy. This sono‐immnotherapy approach demonstrated excellent outcomes in tumor inhibition, eliciting immune responses, and reducing pulmonary fibrosis. Overall, this study offers a new, efficient, and safe method for breast cancer treatment, and expands the application of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyBreast NeoplasmsPulmonary FibrosisUltrasonic TherapyAnimalsFemaleMiceHumansNanoparticlesProtoporphyrinsCell Line, TumorImmune Checkpoint InhibitorsReactive Oxygen SpeciesSilicon Dioxide

Stichwörter der Autor:innen

breast cancerdendritic mesoporous silicapulmonary fibrosissono‐immunotherapy

Substanzen

protoporphyrin IXProtoporphyrinsImmune Checkpoint InhibitorsReactive Oxygen SpeciesSilicon Dioxide

Autor:innen und Institutionen

  • Department of Thyroid-Breast Surgery, The Fourth Affiliated Hospital of Nanjing Medical University, 298 Nanpu Road, Nanjing, Jiangsu, 210032, P. R. China.
  • Breast Disease Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, P. R. China.
  • The Afffliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, 366 Taihu Road, Taizhou, Jiangsu, 225300, P. R. China.
  • Department of Breast surgery, The Affiliated Tumor Hospital of Nantong University, 30 Tongyang north road, Nantong, Jiangsu, 226361, P. R. China.
  • Shanghai Engineering Research Center of Pharmaceutical Intelligent Equipment, Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Non-coding RNA, Institute for Frontier Medical Technology Schoo…

ORCID-Profile: Yu Luo

Förderung

  • National Natural Science Foundation of China
  • Shanghai Shuguang Plan
  • Jiangsu Province Capability Improvement Project through Science, Technology and Education
  • Project of Nantong Health Commission

Zitieren

APA

Li, X., He, G., Jin, H., Xiang, X., Li, D., Peng, R., Tao, J., Li, X., Wang, K., Luo, Y., & Liu, X. (2025). Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis. Advanced Science, 12(5). https://doi.org/10.1002/advs.202407609

Vancouver

Li X, He G, Jin H, Xiang X, Li D, Peng R, et al. Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis. Advanced Science. 2025;12(5). doi:10.1002/advs.202407609

BibTeX
@article{Li2025,
  author = {Li, Xiang and He, Gao and Jin, Hui and Xiang, Xinyu and Li, Dong and Peng, Renmiao and Tao, Jing and Li, Xinping and Wang, Kaiyang and Luo, Yu and Liu, Xiaoan},
  title = {Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {5},
  doi = {10.1002/advs.202407609}
}
Kostenlos starten →